Login / Signup

Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.

Patrick BlinCaroline Dureau-PourninYves CottinJacques BénichouPatrick MismettiAbdelilah AbouelfathRegis LassalleCécile DrozNicholas Moore
Published in: British journal of clinical pharmacology (2018)
In real life D110 and D150 were at least as effective, and safer than VKA.
Keyphrases
  • atrial fibrillation
  • oral anticoagulants
  • catheter ablation
  • left atrial appendage
  • left atrial
  • direct oral anticoagulants
  • heart failure
  • percutaneous coronary intervention
  • mitral valve
  • left ventricular